146 related articles for article (PubMed ID: 29663798)
1. Avoiding Antibiotic Inactivation in Mycobacterium tuberculosis by Rv3406 through Strategic Nucleoside Modification.
Bockman MR; Engelhart CA; Dawadi S; Larson P; Tiwari D; Ferguson DM; Schnappinger D; Aldrich CC
ACS Infect Dis; 2018 Jul; 4(7):1102-1113. PubMed ID: 29663798
[TBL] [Abstract][Full Text] [Related]
2. Targeting Mycobacterium tuberculosis Biotin Protein Ligase (MtBPL) with Nucleoside-Based Bisubstrate Adenylation Inhibitors.
Bockman MR; Kalinda AS; Petrelli R; De la Mora-Rey T; Tiwari D; Liu F; Dawadi S; Nandakumar M; Rhee KY; Schnappinger D; Finzel BC; Aldrich CC
J Med Chem; 2015 Sep; 58(18):7349-7369. PubMed ID: 26299766
[TBL] [Abstract][Full Text] [Related]
3. Bisubstrate adenylation inhibitors of biotin protein ligase from Mycobacterium tuberculosis.
Duckworth BP; Geders TW; Tiwari D; Boshoff HI; Sibbald PA; Barry CE; Schnappinger D; Finzel BC; Aldrich CC
Chem Biol; 2011 Nov; 18(11):1432-41. PubMed ID: 22118677
[TBL] [Abstract][Full Text] [Related]
4. Antitubercular nucleosides that inhibit siderophore biosynthesis: SAR of the glycosyl domain.
Somu RV; Wilson DJ; Bennett EM; Boshoff HI; Celia L; Beck BJ; Barry CE; Aldrich CC
J Med Chem; 2006 Dec; 49(26):7623-35. PubMed ID: 17181146
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel 5-(ethyl or hydroxymethyl) analogs of 2'-'up' fluoro (or hydroxyl) pyrimidine nucleosides as a new class of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium avium inhibitors.
Shakya N; Srivastav NC; Bhavanam S; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R
Bioorg Med Chem; 2012 Jul; 20(13):4088-97. PubMed ID: 22664188
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of chromone, quinolone, and benzoxazinone sulfonamide nucleosides as conformationally constrained inhibitors of adenylating enzymes required for siderophore biosynthesis.
Engelhart CA; Aldrich CC
J Org Chem; 2013 Aug; 78(15):7470-81. PubMed ID: 23805993
[TBL] [Abstract][Full Text] [Related]
7. 2-Aryl-8-aza-3-deazaadenosine analogues of 5'-O-[N-(salicyl)sulfamoyl]adenosine: Nucleoside antibiotics that block siderophore biosynthesis in Mycobacterium tuberculosis.
Krajczyk A; Zeidler J; Januszczyk P; Dawadi S; Boshoff HI; Barry CE; Ostrowski T; Aldrich CC
Bioorg Med Chem; 2016 Jul; 24(14):3133-43. PubMed ID: 27265685
[TBL] [Abstract][Full Text] [Related]
8. Development of small-molecule inhibitors of fatty acyl-AMP and fatty acyl-CoA ligases in Mycobacterium tuberculosis.
Baran M; Grimes KD; Sibbald PA; Fu P; Boshoff HIM; Wilson DJ; Aldrich CC
Eur J Med Chem; 2020 Sep; 201():112408. PubMed ID: 32574901
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and anti-tubercular activity of 2-nitroimidazooxazines with modification at the C-7 position as PA-824 analogs.
Kang YG; Park CY; Shin H; Singh R; Arora G; Yu CM; Lee IY
Bioorg Med Chem Lett; 2015 Sep; 25(17):3650-3. PubMed ID: 26199118
[TBL] [Abstract][Full Text] [Related]
10. Mycobacterium tuberculosis Rv3406 is a type II alkyl sulfatase capable of sulfate scavenging.
Sogi KM; Gartner ZJ; Breidenbach MA; Appel MJ; Schelle MW; Bertozzi CR
PLoS One; 2013; 8(6):e65080. PubMed ID: 23762287
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of siderophore biosynthesis in Mycobacterium tuberculosis with nucleoside bisubstrate analogues: structure-activity relationships of the nucleobase domain of 5'-O-[N-(salicyl)sulfamoyl]adenosine.
Neres J; Labello NP; Somu RV; Boshoff HI; Wilson DJ; Vannada J; Chen L; Barry CE; Bennett EM; Aldrich CC
J Med Chem; 2008 Sep; 51(17):5349-70. PubMed ID: 18690677
[TBL] [Abstract][Full Text] [Related]
12. Investigation of ( S)-(-)-Acidomycin: A Selective Antimycobacterial Natural Product That Inhibits Biotin Synthase.
Bockman MR; Engelhart CA; Cramer JD; Howe MD; Mishra NK; Zimmerman M; Larson P; Alvarez-Cabrera N; Park SW; Boshoff HIM; Bean JM; Young VG; Ferguson DM; Dartois V; Jarrett JT; Schnappinger D; Aldrich CC
ACS Infect Dis; 2019 Apr; 5(4):598-617. PubMed ID: 30652474
[TBL] [Abstract][Full Text] [Related]
13. 2-Carboxyquinoxalines kill mycobacterium tuberculosis through noncovalent inhibition of DprE1.
Neres J; Hartkoorn RC; Chiarelli LR; Gadupudi R; Pasca MR; Mori G; Venturelli A; Savina S; Makarov V; Kolly GS; Molteni E; Binda C; Dhar N; Ferrari S; Brodin P; Delorme V; Landry V; de Jesus Lopes Ribeiro AL; Farina D; Saxena P; Pojer F; Carta A; Luciani R; Porta A; Zanoni G; De Rossi E; Costi MP; Riccardi G; Cole ST
ACS Chem Biol; 2015 Mar; 10(3):705-14. PubMed ID: 25427196
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of
Schumann NC; Lee KJ; Thompson AP; Salaemae W; Pederick JL; Avery T; Gaiser BI; Hodgkinson-Bean J; Booker GW; Polyak SW; Bruning JB; Wegener KL; Abell AD
ACS Chem Biol; 2021 Nov; 16(11):2339-2347. PubMed ID: 34533923
[No Abstract] [Full Text] [Related]
16. Hit discovery of Mycobacterium tuberculosis inosine 5'-monophosphate dehydrogenase, GuaB2, inhibitors.
Sahu NU; Singh V; Ferraris DM; Rizzi M; Kharkar PS
Bioorg Med Chem Lett; 2018 Jun; 28(10):1714-1718. PubMed ID: 29699922
[TBL] [Abstract][Full Text] [Related]
17. Kinetic Analyses of the Siderophore Biosynthesis Inhibitor Salicyl-AMS and Analogues as MbtA Inhibitors and Antimycobacterial Agents.
Bythrow GV; Mohandas P; Guney T; Standke LC; Germain GA; Lu X; Ji C; Levendosky K; Chavadi SS; Tan DS; Quadri LEN
Biochemistry; 2019 Feb; 58(6):833-847. PubMed ID: 30582694
[TBL] [Abstract][Full Text] [Related]
18. A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase Inhibitors.
Esposito M; Szadocka S; Degiacomi G; Orena BS; Mori G; Piano V; Boldrin F; Zemanová J; Huszár S; Barros D; Ekins S; Lelièvre J; Manganelli R; Mattevi A; Pasca MR; Riccardi G; Ballell L; Mikušová K; Chiarelli LR
ACS Infect Dis; 2017 Jun; 3(6):428-437. PubMed ID: 28475832
[TBL] [Abstract][Full Text] [Related]
19. Novel amide and sulphonamide derivatives of 6-(piperazin-1-yl)phenanthridine as potent Mycobacterium tuberculosis H37Rv inhibitors.
Naidu KM; Nagesh HN; Singh M; Sriram D; Yogeeswari P; Gowri Chandra Sekhar KV
Eur J Med Chem; 2015 Mar; 92():415-26. PubMed ID: 25590862
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antimycobacterial activity of 4-[5-(substituted phenyl)-4, 5-dihydro-3-isoxazolyl]-2-methylphenols.
Shaharyar M; Ali MA; Bakht MA; Murugan V
J Enzyme Inhib Med Chem; 2008 Jun; 23(3):432-6. PubMed ID: 18569351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
